Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $5.3250 (-3.36%) ($5.3250 - $5.3250) on Thu. Jul. 29, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.13% (three month average) | RSI | 20 | Latest Price | $5.3250(-3.36%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL declines -2.2% a day on average for past five trading days. | Weekly Trend | AUTL declines -8% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) XBI(54%) ARKG(49%) ARKK(48%) IWO(48%) IBUY(47%) | Factors Impacting AUTL price | AUTL will decline at least -3.065% in a week (0% probabilities). VIXM(-30%) VXX(-28%) SHY(-18%) TLT(-17%) XLU(-14%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.065% (StdDev 6.13%) | Hourly BBV | 0.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-10.36(-294.55%) | Resistance Level | $6.12 | 5 Day Moving Average | $5.43(-1.93%) | 10 Day Moving Average | $5.74(-7.23%) | 20 Day Moving Average | $6.12(-12.99%) | To recent high | -32.9% | To recent low | 6.3% | Market Cap | $278m | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |